BIOMAT Database Logo BIOMAT Database Logo

Effect of stem cell factor on colony growth from acquired and constitutional (Fanconi) aplastic anemia. 1992

G P Bagnara, and P Strippoli, and L Bonsi, and M F Brizzi, and G C Avanzi, and F Timeus, and U Ramenghi, and G Piaggio, and J Tong, and M Podesta
Divisione di Ematologia, Ospedale San Martino, Genova, Italy.

The aim of this study was to evaluate the effect of stem cell factor (SCF) on the in vitro growth of bone marrow hematopoietic progenitors from patients with acquired severe aplastic anemia (AA) or Fanconi's anemia (FA). For this purpose, we studied 11 patients with acquired AA (5 at diagnosis, 6 after ALG treatment), 12 patients with FA, and nine normal controls. Bone marrow cells were plated in vitro for colony-forming unit granulocyte-macrophage (CFU-GM) (in the presence of granulocyte-macrophage colony-stimulating factor [GM-CSF]), and for burst-forming unit-erythroid (BFU-E) and CFU-granulocyte, erythroid, monocyte, megakaryocyte (CFU-GEMM) colonies (in the presence of erythropoietin and interleukin-3 [IL-3]), with or without 20 ng/mL of SCF. In normal controls, SCF enhanced the growth of CFU-GM colonies from 103 to 263 (median), of BFU-E from 168 to 352, and of GEMM colonies from 6 to 38/10(5) cells plated. In patients with acquired AA, SCF induced a significant enhancement of BFU-E growth (8 to 29; P = .01) and allowed the formation of GEMM colonies that were not scored in baseline culture conditions (0 to 8; P = .01). CFU-GM growth was enhanced (4 to 20), but not significantly (P = .3). This was true both for patients at diagnosis and after antilymphocyte globulin treatment. By contrast, 10 of 12 FA patients grew no CFU-GM, BFU-E, or CFU-GEMM colonies, with or without SCF. In two FA patients (one transfusion-dependent and one transfusion-independent), an enhancement of CFU-GM and/or BFU-E was observed. The lack of response of hematopoietic progenitor cells from FA patients to GM-CSF+SCF or IL-3+SCF was not dependent on a defective expression of cytokine receptor messenger RNAs. Northern blot analysis showed in marrow cells from acquired AA and FA patients the presence of normal transcripts for alpha- and beta-chains of GM-CSF/IL-3 receptor and for c-kit protein. In conclusion, SCF promotes the in vitro growth of hematopoietic progenitors in patients with acquired AA, but not in patients with FA, pointing out the intrinsic nature of the defect in the latter disorder.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D008297 Male Males
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D002469 Cell Separation Techniques for separating distinct populations of cells. Cell Isolation,Cell Segregation,Isolation, Cell,Cell Isolations,Cell Segregations,Cell Separations,Isolations, Cell,Segregation, Cell,Segregations, Cell,Separation, Cell,Separations, Cell
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D003114 Colony-Forming Units Assay A cytologic technique for measuring the functional capacity of stem cells by assaying their activity. Clonogenic Cell Assay,Stem Cell Assay,Clonogenic Cell Assays,Colony Forming Units Assays,Colony-Forming Units Assays,Stem Cell Assays,Assay, Clonogenic Cell,Assay, Colony-Forming Units,Assay, Stem Cell,Assays, Clonogenic Cell,Assays, Colony-Forming Units,Assays, Stem Cell,Colony Forming Units Assay
D005199 Fanconi Anemia Congenital disorder affecting all bone marrow elements, resulting in ANEMIA; LEUKOPENIA; and THROMBOPENIA, and associated with cardiac, renal, and limb malformations as well as dermal pigmentary changes. Spontaneous CHROMOSOME BREAKAGE is a feature of this disease along with predisposition to LEUKEMIA. There are at least 7 complementation groups in Fanconi anemia: FANCA, FANCB, FANCC, FANCD1, FANCD2, FANCE, FANCF, FANCG, and FANCL. (from Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id Anemia, Fanconi,Fanconi Hypoplastic Anemia,Fanconi Pancytopenia,Fanconi Panmyelopathy,Fanconi's Anemia,Anemia, Fanconi's,Anemias, Fanconi,Fanconi Anemias

Related Publications

G P Bagnara, and P Strippoli, and L Bonsi, and M F Brizzi, and G C Avanzi, and F Timeus, and U Ramenghi, and G Piaggio, and J Tong, and M Podesta
In vitro effect of stem cell factor on colony growth from acquired severe aplastic anemia.
July 1993, Stem cells (Dayton, Ohio),
G P Bagnara, and P Strippoli, and L Bonsi, and M F Brizzi, and G C Avanzi, and F Timeus, and U Ramenghi, and G Piaggio, and J Tong, and M Podesta
Fanconi anemia: constitutional aplastic anemia.
April 1991, Seminars in hematology,
G P Bagnara, and P Strippoli, and L Bonsi, and M F Brizzi, and G C Avanzi, and F Timeus, and U Ramenghi, and G Piaggio, and J Tong, and M Podesta
[Constitutional aplastic anemia (Fanconi type)].
January 1977, Bilten za hematologiju i transfuziju,
G P Bagnara, and P Strippoli, and L Bonsi, and M F Brizzi, and G C Avanzi, and F Timeus, and U Ramenghi, and G Piaggio, and J Tong, and M Podesta
[Constitutional aplastic anemia (Fanconi syndrome)].
April 1965, Dapim refuiim. Folia medica,
G P Bagnara, and P Strippoli, and L Bonsi, and M F Brizzi, and G C Avanzi, and F Timeus, and U Ramenghi, and G Piaggio, and J Tong, and M Podesta
[Congenital aplastic anemia (constitutional, hereditary) Fanconi type].
September 1974, Srpski arhiv za celokupno lekarstvo,
G P Bagnara, and P Strippoli, and L Bonsi, and M F Brizzi, and G C Avanzi, and F Timeus, and U Ramenghi, and G Piaggio, and J Tong, and M Podesta
Hematopoietic stem cell transplantation for acquired aplastic anemia.
November 2016, Current opinion in hematology,
G P Bagnara, and P Strippoli, and L Bonsi, and M F Brizzi, and G C Avanzi, and F Timeus, and U Ramenghi, and G Piaggio, and J Tong, and M Podesta
[Hematopoietic stem cell transplantation for acquired aplastic anemia].
October 2015, [Rinsho ketsueki] The Japanese journal of clinical hematology,
G P Bagnara, and P Strippoli, and L Bonsi, and M F Brizzi, and G C Avanzi, and F Timeus, and U Ramenghi, and G Piaggio, and J Tong, and M Podesta
Constitutional aplastic anemia.
May 1988, Indian pediatrics,
G P Bagnara, and P Strippoli, and L Bonsi, and M F Brizzi, and G C Avanzi, and F Timeus, and U Ramenghi, and G Piaggio, and J Tong, and M Podesta
Fanconi anaemia--constitutional, familial aplastic anaemia.
January 1989, Bailliere's clinical haematology,
G P Bagnara, and P Strippoli, and L Bonsi, and M F Brizzi, and G C Avanzi, and F Timeus, and U Ramenghi, and G Piaggio, and J Tong, and M Podesta
[Clinical effect of recombinant human granulocyte colony-stimulating factor on aplastic anemia].
September 1990, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Copied contents to your clipboard!